# Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery

> **NCT07006467** · NA · RECRUITING · sponsor: **Stentit** · enrollment: 10 (estimated)

## Conditions studied

- Critical Limb Ischemia (CLI)

## Interventions

- **DEVICE:** Implantation of RFS

## Key facts

- **NCT ID:** NCT07006467
- **Lead sponsor:** Stentit
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-03
- **Primary completion:** 2025-09-30
- **Final completion:** 2027-08-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07006467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07006467, "Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore Lumen Patency and Blood Flow to Infrapopliteal Arteries. The RFS is a Fully Electrospun Tubular Device With a Fibrillated Microarchitecture and Designed for Transcatheter Delivery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07006467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*